Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 6: Complication rates with different flow diverters including the period under review
Author Year Flow Diverter No. of Patients Thromboembolic Complications Hemorrhagic Complications Median Follow-Up Time (mo)
Möhlenbruch et al⁸ 2015 FRED 29 14.0% 3.0% 6
Poncyljusz et al¹¹ 2013 FRED 6 17.0% 0.0% 3
Briganti et al¹² 2016 FRED 20 0.0% 0.0% 12
Lubicz et al¹³ 2015 Silk 26 23.1% 11.5% 6
Briganti et al⁴ 2012 Silk + Pipeline 273 4.8% 5.5% 3
Colby et al⁷ 2016 Pipeline Flex 44 2.0% 0.0% Not applicable
De Vries et al¹⁴ 2013 Surpass 37 13.5% 5.4% 12
Fischer et al¹⁵ 2015 p64 130 3.0% 0.0% 9
Our data 2016 FRED 48 15.4% 1.9% 12

Author	Year	Flow Diverter	No. of Patients	Thromboembolic Complications	Hemorrhagic Complications	Median Follow-Up Time (mo)
Möhlenbruch et al⁸	2015	FRED	29	14.0%	3.0%	6
Poncyljusz et al¹¹	2013	FRED	6	17.0%	0.0%	3
Briganti et al¹²	2016	FRED	20	0.0%	0.0%	12
Lubicz et al¹³	2015	Silk	26	23.1%	11.5%	6
Briganti et al⁴	2012	Silk + Pipeline	273	4.8%	5.5%	3
Colby et al⁷	2016	Pipeline Flex	44	2.0%	0.0%	Not applicable
De Vries et al¹⁴	2013	Surpass	37	13.5%	5.4%	12
Fischer et al¹⁵	2015	p64	130	3.0%	0.0%	9
Our data	2016	FRED	48	15.4%	1.9%	12